X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NBSE

Closed

Neubase Therapeutics Inc

0.378
0.000 (0.00%)
Last Update: 24 May 2024 16:30:00
Yesterday: 0.378
Day's Range: 0.378 - 0.378
Send
When Written:
 
0.1693
NeuBase Therapeutics Inc. is a biotechnology company that is focused on developing therapies for a variety of genetic diseases. The company's proprietary technology platform, called PATrOL™, is designed to enable the development of highly specific and effective therapies that target genetic mutations at the RNA level. NeuBase's lead product candidate is a treatment for Huntington's disease, a genetic disorder that affects the brain and nervous system. The company is also developing therapies for other genetic diseases, including myotonic dystrophy and familial amyloidosis. NeuBase is headquartered in Pittsburgh, Pennsylvania and was founded in 2018.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X